Clinical Trials on All Tumor Types in Netherlands

Total 12257 results

University Medical Center Groningen

Completed

Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor (WIN)

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study (VIDEO-NET)

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

Optimal Feeding for NET Patients (DIVIT-pilot)

Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study (WIN)

Quality of Life | Distress | Neuroendocrine Tumor

Netherlands
University Medical Center Groningen

Completed

Repeat CT for Evaluation of Inter- and Intrafraction Changes During Curative Thoracic Radiotherapy (REACT)

Thoracic Tumor

Netherlands
University Medical Center Groningen

Completed

Repeat CT Scans for Evaluation of Inter- and Intrafraction Motion and it's Effect on Radiotherapy Dose Distribution During Curative Radiotherapy for Pelvic Tumours (RACE)

Pelvic Tumor

Netherlands
J.M. de Laat
Radboud University Medical Center; University Medical Center Groningen; Maastricht... and other collaborators

Recruiting

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients (PRIME)

Multiple Endocrine Neoplasia Type 1 | Neuroendocrine Tumor of Pancreas

Netherlands
Leiden University Medical Center

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

Giant Cell Tumor of Bone | Osteoclastoma

Netherlands, Belgium
European Organisation for Research and Treatment...
Amgen

Terminated

Reduced Dose-density of Denosumab for Unresectable GCTB (REDUCE)

Bone Giant Cell Tumor

Spain, United Kingdom, Italy, Netherlands
University Medical Center Groningen
Dutch Cancer Society

Recruiting

GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

Gastro-intestinal Stromal Tumor

Netherlands
Radboud University Medical Center

Terminated

Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy (ABILITY)

Gastrointestinal Stromal Tumor | Major Gastrectomy

Netherlands
University Medical Center Groningen

Completed

Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. (BANN)

Carcinoma, Renal Cell | Carcinoma | Neuroendocrine Tumors | Carcinoid Tumor | Pancreatic Islet Cell Tumors

Netherlands
Maastricht University Medical Center

Unknown

Everolimus TDM to Predict Long Term Toxicity (Foresight)

Renal Cell Carcinoma | Breast Cancer | Neuroendocrine Neoplasm of Lung | Pancreatic Neuroendocrine Tumour | Gastrointestinal Neuroendocrine Tumour

Netherlands
University Hospital, Antwerp
Erasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research... and other collaborators

Recruiting

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients (SAUNA)

Gastroenteropancreatic Neuroendocrine Tumor

Netherlands, Belgium
Regeneron Pharmaceuticals

Recruiting

A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab

Advanced Solid Tumor | Metastatic Solid Tumor

Netherlands
AmMax Bio, Inc.

Active, not recruiting

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Tenosynovial Giant Cell Tumor | Pigmented Villonodular Synovitis

Poland, Ukraine, United States, Netherlands
University Medical Center Groningen

Completed

Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis (HET-NET)

Neuroendocrine Tumors

Netherlands
AmMax Bio, Inc.

Recruiting

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Tenosynovial Giant Cell Tumor | Pigmented Villonodular Synovitis | TGCT

Netherlands, Australia, United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch Cancer Society

Unknown

Pediatric Research on Improving Speed, Memory and Attention (PRISMA)

Brain Tumors

Netherlands
University Medical Center Groningen

Completed

Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT) (CROSS SECT)

Thoracic Tumor

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma (RACCOON)

Perihilar Cholangiocarcinoma

Netherlands
Leiden University Medical Center

Recruiting

Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green

Paraganglioma

Netherlands
University Medical Center Groningen

Completed

5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor' (5-HIAA)

Neuroendocrine Tumors

Netherlands
University Medical Center Groningen

Completed

The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors

Neuroendocrine Tumors

Netherlands
University Medical Center Groningen
Novartis Pharmaceuticals

Completed

89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors (NETPET)

Neuroendocrine Tumors

Netherlands
Advanced Accelerator Applications

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NETTER-2)

Gastro-enteropancreatic Neuroendocrine Tumor

Spain, United States, United Kingdom, France, Canada, Germany, Netherlands, Italy, Korea, Republic of
University Medical Center Groningen
Radboud University Medical Center; Maastricht University Medical Center; UMC... and other collaborators

Completed

Phenoxybenzamine Versus Doxazosin in PCC Patients (PRESCRIPT)

Pheochromocytoma

Netherlands
Radboud University Medical Center

Recruiting

Exendin PET/CT for Imaging of Paragangliomas (ENTRAP)

Paraganglioma

Netherlands
Radboud University Medical Center

Completed

myDC/pDC in Stage III Melanoma Patients

Melanoma

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String (CHORDA-II-p)

Perihilar Cholangiocarcinoma

Netherlands
University Medical Center Groningen

Recruiting

Fluorescence Image Guided Surgery in Cholangiocarcinoma (COUGAR)

Hilar Cholangiocarcinoma

Netherlands
University Medical Center Groningen
VHL Alliance

Completed

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (VHLimage)

Renal Cell Carcinoma | Von Hippel-Lindau Disease | Pheochromocytoma | Pancreatic Neuroendocrine Tumor | Hemangioblastoma

Netherlands
Amsterdam UMC, location VUmc

Recruiting

A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme (STELLAR)

Glioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain Tumor

Netherlands
Radboud University Medical Center

Completed

Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients

Melanoma

Netherlands
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
Modra Pharmaceuticals

Withdrawn

Absorption and Excretion of Oral Docetaxel

Solid Tumor, Adult

Netherlands
Erasmus Medical Center

Completed

(68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors

Malignant Brain Tumors

Netherlands
UMC Utrecht

Completed

Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study (HEPAR_Plus)

Neuroendocrine Tumors

Netherlands
The Netherlands Cancer Institute
4SC

Active, not recruiting

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI)

Malignant Melanoma Stage III

Netherlands
A.J.M. van den Eertwegh
Idera Pharmaceuticals, Inc.

Recruiting

A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma (INTRIM)

Malignant Melanoma

Netherlands
CytomX Therapeutics

Terminated

PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid Tumors

Solid Tumor | Unresectable or Metastatic Melanoma

Korea, Republic of, United States, Netherlands, Spain, Australia
Centre Leon Berard
Ministry of Health, France

Completed

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Pigmented Villonodular Synovitis

France, Netherlands, Italy, Poland, United Kingdom
Erasmus Medical Center

Recruiting

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses (Radio-Marker)

Neuroendocrine Tumors

Netherlands
Zuyderland Medisch Centrum

Recruiting

Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients (SCARLETT)

Melanoma

Netherlands
Zuyderland Medisch Centrum

Completed

Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients (TRACIE)

Melanoma

Netherlands
Radboud University Medical Center

Completed

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Melanoma

Netherlands
The Netherlands Cancer Institute
Merck Sharp & Dohme LLC

Unknown

Study Comparing Pembrolizumab With Dual MAPK Pathway Inhibition Plus Pembrolizumab in Melanoma Patients (IMPemBra)

Metastatic Melanoma

Netherlands
Galina Velikova
The Leeds Teaching Hospitals NHS Trust; European Organisation for Research...

Completed

Long Term Implications of Rare Brain Tumours'

Quality of Life | Cognitive Impairment | Health-related Quality of Life | Long-term Effects of Cancer Treatment | WHO Grade II Oligodendroglial Tumor | WHO Grade III Oligodendroglial Tumor

Netherlands, United Kingdom
The Netherlands Cancer Institute

Recruiting

FMT to Convert Response to Immunotherapy

Melanoma Stage IV | Melanoma Stage III

Netherlands

Clinical Trials on All Tumor Types in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations